Gag cytotoxic T lymphocyte escape mutations can increase sensitivity of HIV-1 to human TRIM5α, linking intrinsic and acquired immunity

Journal of Virology

Volumn 85, Issue 22, 2011, Pages 11846-11854

  Battivelli, Emilie ^a,b   Migraine, Julie ^a,b   Lecossier, Denise ^a,b   Yeni, Patrick ^c   Clavel, François ^a,b   Hance, Allan J ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DIDEROT   (France)

^c BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAG PROTEIN; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; TRIPARTITE MOTIF PROTEIN 5;

ADAPTIVE IMMUNITY; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE EVASION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; VIRUS CAPSID; VIRUS INFECTIVITY; VIRUS MUTATION; VIRUS RESISTANCE;

CAPSID PROTEINS; CARRIER PROTEINS; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HIV-1; HUMANS; MUTAGENESIS, SITE-DIRECTED; MUTATION, MISSENSE; RECOMBINATION, GENETIC; T-LYMPHOCYTES, CYTOTOXIC;

HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

EID: 80655142502     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05201-11     Document Type: Article

References (74)

1. Aickin, M., and H. Gensler. 1996. Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods. Am. J. Public Health 86:726-728.
2. + T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J. Virol. 79:13239-13249.
3. Allen, T. M., et al. 2004. Selection, transmission, and reversion of an antigenprocessing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection. J. Virol. 78:7069-7078.
4. Bailey, J. R., et al. 2008. Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor. J. Virol. 82:7395-7410.
5. Battivelli, E., et al. 2010. Strain-specific differences in the impact of human TRIM5alpha, different TRIM5alpha alleles, and the inhibition of capsidcyclophilin A interactions on the infectivity of HIV-1. J. Virol. 84:11010- 11019.
6. Borghans, J. A., A. Molgaard, R. J. de Boer, and C. Kesmir. 2007. HLA alleles associated with slow progression to AIDS truly prefer to present HIV-1 p24. PLoS One 2:e920.
7. Brockman, M. A., et al. 2010. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection. J. Virol. 84:11937-11949.
8. Brockman, M. A., et al. 2007. Escape and compensation from early HLAB57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. J. Virol. 81: 12608-12618.
9. Brumme, Z. L., et al. 2009. HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins. PLoS One 4:e6687.
10. Cagliani, R., et al. 2010. Long-term balancing selection maintains transspecific polymorphisms in the human TRIM5 gene. Hum. Genet. 128:577- 588.
11. Carlson, J. M., et al. 2008. Phylogenetic dependency networks: inferring patterns of CTL escape and codon covariation in HIV-1 Gag. PLoS Comput. Biol. 4:e1000225.
12. Carrington, M., and S. J. O'Brien. 2003. The influence of HLA genotype on AIDS. Annu. Rev. Med. 54:535-551.
13. Carthagena, L., et al. 2008. Implication of TRIM alpha and TRIMCyp in interferon-induced anti-retroviral restriction activities. Retrovirology 5:59.
14. Chatterji, U., et al. 2005. Naturally occurring capsid substitutions render HIV-1 cyclophilin A independent in human cells and TRIM-cyclophilinresistant in owl monkey cells. J. Biol. Chem. 280:40293-40300.
15. Chopera, D. R., et al. 2008. Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage. PLoS Pathog. 4:e1000033.
16. Crawford, H., et al. 2009. Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients. J. Exp. Med. 206:909-921.
17. Crawford, H., et al. 2007. Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLAB* 5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. J. Virol. 81:8346-8351.
18. Draenert, R., et al. 2004. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J. Exp. Med. 199:905-915.
19. Fitzon, T., et al. 2000. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication. Virology 268:294-307.
20. Forshey, B. M., U. von Schwedler, W. I. Sundquist, and C. Aiken. 2002. Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J. Virol. 76:5667-5677.
21. Frahm, N., et al. 2005. HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load. J. Virol. 79:10218-10225.
22. Gamble, T. R., et al. 1996. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 87:1285-1294.
23. Goepfert, P. A., et al. 2008. Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. J. Exp. Med. 205:1009-1017.
24. Goldschmidt, V., et al. 2006. Role of common human TRIM5alpha variants in HIV-1 disease progression. Retrovirology 3:54.
25. Goulder, P. J., et al. 1997. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 3:212-217.
26. Goulder, P. J., and D. I. Watkins. 2008. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat. Rev. Immunol. 8:619-630.
27. Hatziioannou, T., D. Perez-Caballero, S. Cowan, and P. D. Bieniasz. 2005. Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells. J. Virol. 79: 176-183.
28. + T-cell epitopes. J. Virol. 81:3667-3672.
29. Ikeda, Y., L. M. Ylinen, M. Kahar-Bador, and G. J. Towers. 2004. Influence of gag on human immunodeficiency virus type 1 species-specific tropism. J. Virol. 78:11816-11822.
30. Javanbakht, H., et al. 2006. Characterization of TRIM5alpha trimerization and its contribution to human immunodeficiency virus capsid binding. Virology 353:234-246.
31. Johnson, W. E., and S. L. Sawyer. 2009. Molecular evolution of the antiretroviral TRIM5 gene. Immunogenetics 61:163-176.
32. Keckesova, Z., L. M. Ylinen, and G. J. Towers. 2006. Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 alpha antiviral activity. J. Virol. 80:4683-4690.
33. Kelleher, A. D., et al. 2001. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J. Exp. Med. 193:375-386.
34. Kiepiela, P., et al. 2004. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432:769-775.
35. Kim, J., C. Tipper, and J. Sodroski. 2011. Role of the TRIM5α RING domain E3 ubiquitin ligase activity in capsid disassembly, reverse transcription blockade and restriction of simian immunodeficiency virus. J. Virol. 85:8116-8132.
36. Kootstra, N. A., M. Navis, C. Beugeling, K. A. van Dort, and H. Schuitemaker. 2007. The presence of the Trim5alpha escape mutation H87Q in the capsid of late stage HIV-1 variants is preceded by a prolonged asymptomatic infection phase. AIDS 21:2015-2023.
37. Lazaro, E., et al. 2005. Sequences of clustered epitopes in Gag and Nef potentially presented by predominant class I human leukocyte antigen (HLA) alleles A and B expressed by human immunodeficiency virus type 1 (HIV-1)-infected patients in Vietnam. AIDS Res. Hum. Retroviruses 21: 586-591.
38. Leslie, A., et al. 2006. Differential selection pressure exerted on HIV by CTL targeting identical epitopes but restricted by distinct HLA alleles from the same HLA supertype. J. Immunol. 177:4699-4708.
39. Leslie, A. J., et al. 2004. HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 10:282-289.
40. Li, B., et al. 2007. Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution. J. Virol. 81:193-201.
41. Liang, B., M. Luo, T. B. Ball, S. J. Jones, and F. A. Plummer. 2010. QUASI analysis of host immune responses to Gag polyproteins of human immunodeficiency virus type 1 by a systematic bioinformatics approach. Biochem. Cell Biol. 88:671-681.
42. Liu, Y., et al. 2007. Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape. J. Virol. 81:12179-12188.
43. Luban, J. 2007. Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection. J. Virol. 81:1054-1061.
44. Martinez-Picado, J., et al. 2006. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J. Virol. 80:3617-3623.
45. Matsuoka, S., E. Dam, D. Lecossier, F. Clavel, and A. J. Hance. 2009. Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type. Retrovirology 6:21.
46. Matthews, P. C., et al. 2009. HLA footprints on human immunodeficiency virus type 1 are associated with interclade polymorphisms and intraclade phylogenetic clustering. J. Virol. 83:4605-4615.
47. McMichael, A., and P. Klenerman. 2002. HIV/AIDS. HLA leaves its footprints on HIV. Science 296:1410-1411.
48. + longterm nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences. J. Virol. 77:6889-6898.
49. Miura, T., et al. 2009. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphotye [sic] recognition. J. Virol. 83:2743-2755. (Erratum, 83:5961.)
50. Moore, C. B., et al. 2002. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296:1439-1443.
51. Navis, M., et al. 2007. Viral replication capacity as a correlate of HLA B57/B5801-associated nonprogressive HIV-1 infection. J. Immunol. 179: 3133-3143.
52. Newman, R. M., and W. E. Johnson. 2007. A brief history of TRIM5alpha. AIDS Rev. 9:114-125.
53. O'Connell, K. A., et al. 2010. Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus. J. Virol. 84:7018-7028.
54. Pereyra, F., et al. 2010. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. International HIV Controllers Study. Science 330:1551-1557.
55. Pertel, T., et al. 2011. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472:361-365.
56. Peters, H. O., et al. 2008. An integrative bioinformatic approach for studying escape mutations in human immunodeficiency virus type 1 gag in the Pumwani sex worker cohort. J. Virol. 82:1980-1992.
57. Price, D. A., et al. 2004. T cell receptor recognition motifs govern immune escape patterns in acute SIV infection. Immunity 21:793-803.
58. Sakuma, R., A. A. Mael, and Y. Ikeda. 2007. Alpha interferon enhances TRIM5alpha-mediated antiviral activities in human and rhesus monkey cells. J. Virol. 81:10201-10206.
59. Sawyer, S. L., L. I. Wu, J. M. Akey, M. Emerman, and H. S. Malik. 2006. High-frequency persistence of an impaired allele of the retroviral defense gene TRIM5alpha in humans. Curr. Biol. 16:95-100.
60. Schneidewind, A., et al. 2008. Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLAB27-restricted epitope in human immunodeficiency virus type 1 capsid. J. Virol. 82:5594-5605.
61. Schneidewind, A., et al. 2007. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J. Virol. 81:12382-12393.
62. Schneidewind, A., et al. 2009. Transmission and long-term stability of compensated CD8 escape mutations. J. Virol. 83:3993-3997.
63. Schneidewind, A., et al. 2009. Maternal transmission of human immunodeficiency virus escape mutations subverts HLA-B57 immunodominance but facilitates viral control in the haploidentical infant. J. Virol. 83:8616-8627.
64. Sewram, S., et al. 2009. Human TRIM5alpha expression levels and reduced susceptibility to HIV-1 infection. J. Infect. Dis. 199:1657-1663.
65. Sokolskaja, E., L. Berthoux, and J. Luban. 2006. Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells. J. Virol. 80:2855-2862.
66. Stremlau, M., et al. 2004. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427:848-853.
67. Stremlau, M., et al. 2006. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc. Natl. Acad. Sci. U. S. A. 103:5514-5519.
68. Stremlau, M., B. Song, H. Javanbakht, M. Perron, and J. Sodroski. 2006. Cyclophilin A: an auxiliary but not necessary cofactor for TRIM5alpha restriction of HIV-1. Virology 351:112-120.
69. Thobakgale, C. F., et al. 2009. Impact of HLA in mother and child on disease progression of pediatric human immunodeficiency virus type 1 infection. J. Virol. 83:10234-10244.
70. Towers, G. J. 2007. The control of viral infection by tripartite motif proteins and cyclophilin A. Retrovirology 4:40.
71. Troyer, R. M., et al. 2009. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response. PLoS Pathog. 5:e1000365.
72. Virgin, H. W., and B. D. Walker. 2010. Immunology and the elusive AIDS vaccine. Nature 464:224-231.
73. + T-cell responses following acute HIV-1 infection. J. Virol. 76:8690- 8701.
74. Yu, X. G., et al. 2007. Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes. J. Virol. 81:1619-1631.